Guided Therapeutics (GTHP) Other Working Capital Changes (2011 - 2026)
Guided Therapeutics (GTHP) posted Other Working Capital Changes of -$22000.0 for Q4 2025, up 18.52% sequentially from -$27000.0 in Q3 2025, and up 12.0% YoY from -$19642.9 in Q4 2024.
Guided Therapeutics (GTHP) Other Working Capital Changes (2011 - 2026) Analysis & Trends
Guided Therapeutics has reported Other Working Capital Changes for 6 years, with the latest figure at -$22000.0 in Q4 2025.
- Quarterly Other Working Capital Changes rose 12.0% year-over-year to -$22000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$100000.0 (down 8.7% YoY) and the FY2025 annual result came in at -$100000.0, down 8.7% from the prior year.
- Other Working Capital Changes improved to -$22000.0 in Q4 2025 per GTHP's latest filing, from -$27000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $507000.0 in Q4 2024 and troughed at -$507000.0 in Q3 2022.
- A 5-year average of $8222.2 and a median of -$8000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes soared 53.66% in 2022, then slumped 31.25% in 2023.
- Over 5 years, Other Working Capital Changes stood at -$15000.0 in 2021, then slipped by 6.67% to -$16000.0 in 2022, then plunged by 31.25% to -$21000.0 in 2023, then slipped by 19.05% to -$25000.0 in 2024, then gained by 12.0% to -$22000.0 in 2025.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$22000.0, -$27000.0, and -$26000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -58,000.00 |
| Jun 30, 2026 | -58,000.00 |
| Jun 30, 2026 | -58,000.00 |
| Mar 31, 2026 | -21,000.00 |
| Mar 31, 2026 | -21,000.00 |
| Mar 31, 2026 | -21,000.00 |
| Dec 31, 2025 | -485,000.00 |
| Dec 31, 2025 | -485,000.00 |
| Dec 31, 2025 | -485,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Sep 30, 2025 | -5,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Jun 30, 2025 | -59,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Mar 31, 2025 | -111,000.00 |
| Dec 31, 2024 | 507,000.00 |
| Dec 31, 2024 | 507,000.00 |